The present results highlight potentially therapeutic benefits of intrastriatal autograft cell transplantation of tyrosinase-expressing melanocytes in PD patients, because the autograft cell transplantation can avoid or reduce immunological, ethical and social concerns. The gene discussed is TYR; the disease is Parkinson disease.